Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - Toronto Stock Exchange - CA2208741017 - Common Stock - Currency: CAD

0.1  +0.01 (+5.26%)

Fundamental Rating

2

Overall CJR-B gets a fundamental rating of 2 out of 10. We evaluated CJR-B against 11 industry peers in the Media industry. CJR-B has a bad profitability rating. Also its financial health evaluation is rather negative. CJR-B has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CJR-B had negative earnings in the past year.
In the past year CJR-B had a positive cash flow from operations.
CJR-B had negative earnings in 4 of the past 5 years.
In the past 5 years CJR-B always reported a positive cash flow from operatings.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

The Return On Assets of CJR-B (-47.42%) is worse than 81.82% of its industry peers.
CJR-B has a Return On Invested Capital of 6.43%. This is in the better half of the industry: CJR-B outperforms 63.64% of its industry peers.
CJR-B had an Average Return On Invested Capital over the past 3 years of 8.40%. This is significantly below the industry average of 32.97%.
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROIC 6.43%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CJR-B has a Operating Margin of 9.12%. This is in the better half of the industry: CJR-B outperforms 72.73% of its industry peers.
In the last couple of years the Operating Margin of CJR-B has declined.
CJR-B has a better Gross Margin (53.83%) than 81.82% of its industry peers.
In the last couple of years the Gross Margin of CJR-B has declined.
Industry RankSector Rank
OM 9.12%
PM (TTM) N/A
GM 53.83%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1

2. Health

2.1 Basic Checks

CJR-B has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CJR-B has about the same amout of shares outstanding than it did 1 year ago.
CJR-B has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CJR-B is higher compared to a year ago.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -1.48, we must say that CJR-B is in the distress zone and has some risk of bankruptcy.
CJR-B has a Altman-Z score of -1.48. This is in the lower half of the industry: CJR-B underperforms 63.64% of its industry peers.
CJR-B has a debt to FCF ratio of 12.33. This is a negative value and a sign of low solvency as CJR-B would need 12.33 years to pay back of all of its debts.
CJR-B has a worse Debt to FCF ratio (12.33) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Altman-Z -1.48
ROIC/WACC1.55
WACC4.14%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.65 indicates that CJR-B may have some problems paying its short term obligations.
CJR-B has a Current ratio of 0.65. This is amonst the worse of the industry: CJR-B underperforms 90.91% of its industry peers.
CJR-B has a Quick Ratio of 0.65. This is a bad value and indicates that CJR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.65, CJR-B is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -186.36% in the last year.
Measured over the past years, CJR-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -43.12% on average per year.
CJR-B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.72%.
The Revenue has been decreasing by -5.52% on average over the past years.
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%

3.2 Future

CJR-B is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.99% yearly.
Based on estimates for the next years, CJR-B will show a decrease in Revenue. The Revenue will decrease by -5.42% on average per year.
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CJR-B. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CJR-B. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

90.91% of the companies in the same industry are more expensive than CJR-B, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CJR-B indicates a rather cheap valuation: CJR-B is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.23
EV/EBITDA 1.36
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

CJR-B's earnings are expected to decrease with -25.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%

0

5. Dividend

5.1 Amount

CJR-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (6/11/2025, 7:00:00 PM)

0.1

+0.01 (+5.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)06-25 2025-06-25
Inst Owners4.14%
Inst Owner ChangeN/A
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap19.61M
Analysts43.08
Price Target0.09 (-10%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.25%
Min EPS beat(2)-75.76%
Max EPS beat(2)33.26%
EPS beat(4)2
Avg EPS beat(4)-55.69%
Min EPS beat(4)-251.7%
Max EPS beat(4)71.44%
EPS beat(8)5
Avg EPS beat(8)-5.39%
EPS beat(12)5
Avg EPS beat(12)-171.05%
EPS beat(16)8
Avg EPS beat(16)-128.06%
Revenue beat(2)0
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-3.66%
Max Revenue beat(2)-2.96%
Revenue beat(4)0
Avg Revenue beat(4)-5.28%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-2.96%
Revenue beat(8)0
Avg Revenue beat(8)-4.35%
Revenue beat(12)1
Avg Revenue beat(12)-3.71%
Revenue beat(16)1
Avg Revenue beat(16)-3.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-140%
EPS NY rev (1m)0%
EPS NY rev (3m)-199.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.23
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 1.36
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.43
FCFY432.69%
OCF(TTM)0.51
OCFY505.08%
SpS6.11
BVpS-2.18
TBVpS-7.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROCE 8.92%
ROIC 6.43%
ROICexc 6.95%
ROICexgc 277.86%
OM 9.12%
PM (TTM) N/A
GM 53.83%
FCFM 7.08%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Debt/EBITDA 1.45
Cap/Depr 2.33%
Cap/Sales 1.18%
Interest Coverage 1.65
Cash Conversion 13.8%
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z -1.48
F-Score4
WACC4.14%
ROIC/WACC1.55
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A
EBIT growth 1Y-40.38%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year0.25%
EBIT Next 3Y6.51%
EBIT Next 5YN/A
FCF growth 1Y-31.59%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-29.84%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%